Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Why Avoid Individual Stocks highlights the risks of single-stock bets and why broad index funds offer steadier long-term growth for most investors.
22,058 articlesBiotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Arm is venturing into silicon design after decades as a licensing powerhouse. This bold shift could impact AI data ce...
CDL, the VictoryShares US Large Cap High Div Volatility Wtd ETF, continues to deliver a steady income stream with cdl...
Investing in AI stocks can feel like a fast-moving target. This article breaks down whether penguin solutions next st...
Two very different approaches to growth: Nvidia leads AI hardware and software, while Strategy blends software with B...
In the first half of 2026, Upstart stock fell about 19%, shaking confidence in a fintech darling. This article breaks...
Palantir has slipped significantly from its all-time high, prompting questions about a buy-the-dip opportunity. This ...
In 2026, breadth returns as equal-weight ETFs beat the S&P 500, nudging investors toward diversified exposure. Here a...
MicroStrategy, the world's largest corporate holder of Bitcoin, announced a major bond buyback this week, signaling a...
When a founder makes a sky‑high forecast, investors scramble. This article breaks down elon musk just made claims abo...
The era of persistently higher rates is reshaping life insurers' economics. MetLife and Prudential stand to benefit a...
When rhythm pharma (rytm) releases earnings, investors get a window into revenue growth, cash health, and pipeline pr...